StockNews.com lowered shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) from a strong-buy rating to a buy rating in a research note published on Thursday morning.
Other equities analysts have also issued reports about the stock. B. Riley began coverage on shares of Tactile Systems Technology in a report on Thursday, September 26th. They issued a “buy” rating and a $23.00 target price on the stock. BTIG Research downgraded Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research report on Tuesday, November 5th. Finally, Oppenheimer cut Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th.
Read Our Latest Research Report on TCMD
Tactile Systems Technology Stock Down 0.2 %
Hedge Funds Weigh In On Tactile Systems Technology
Several large investors have recently bought and sold shares of TCMD. Rhumbline Advisers increased its position in Tactile Systems Technology by 11.6% in the 2nd quarter. Rhumbline Advisers now owns 39,318 shares of the company’s stock valued at $469,000 after acquiring an additional 4,099 shares during the period. American Century Companies Inc. lifted its position in shares of Tactile Systems Technology by 59.7% in the 2nd quarter. American Century Companies Inc. now owns 25,711 shares of the company’s stock worth $307,000 after purchasing an additional 9,608 shares during the period. Federated Hermes Inc. boosted its stake in shares of Tactile Systems Technology by 26.5% in the 2nd quarter. Federated Hermes Inc. now owns 433,660 shares of the company’s stock valued at $5,178,000 after purchasing an additional 90,960 shares during the last quarter. Magnetar Financial LLC acquired a new stake in shares of Tactile Systems Technology during the second quarter worth $130,000. Finally, Paradigm Capital Management Inc. NY raised its stake in Tactile Systems Technology by 90.1% during the second quarter. Paradigm Capital Management Inc. NY now owns 1,183,800 shares of the company’s stock worth $14,135,000 after buying an additional 561,073 shares during the last quarter. 83.43% of the stock is currently owned by institutional investors.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Read More
- Five stocks we like better than Tactile Systems Technology
- Consumer Discretionary Stocks Explained
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- What is an Earnings Surprise?
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Canada Bond Market Holiday: How to Invest and Trade
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.